Radiation Response Modulation of GW572016 (EGFR/HER2 Dual Tyrosine Kinase Inhibitor) in Human Breast Cancer Xenografts |
Kim, Yeon-Sil
(Department of Radiation Oncology, The Catholic University of Korea, College of Medicine)
Roh, Kwang-Won (Department of Radiation Oncology, The Catholic University of Korea, College of Medicine) Chae, Soo-Min (Department of Radiation Oncology, The Catholic University of Korea, College of Medicine) Mun, Seong-Kwon (Department of Radiation Oncology, Eulji University Hospital) Yoon, Sei-Chul (Department of Radiation Oncology, The Catholic University of Korea, College of Medicine) Jang, Hong-Seok (Department of Radiation Oncology, The Catholic University of Korea, College of Medicine) Chung, Su-Mi (Department of Radiation Oncology, The Catholic University of Korea, College of Medicine) |
1 | Yarden Y. The EGFR family and its ligands in human cancer. Signaling mechanism and therapeutic opportunities. E J Cancer 2001;4(suppl):S3‐8 |
2 | Kwok TT, Sutherland RM. Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors. Br J Cancer 1991;64:251–254 |
3 | Todd DG, Mikkelsen RB, Rorrer WK, et al. Ionizing radiation stimulates existing signal transduction pathways involving the activation of epidermal growth factor receptor and ERBB-3, and changes of intracellular calcium in A431 human squamous carcinoma cells. J Recept Signal Transduct Res 1999;19:885–908 |
4 | Zhou H, Kim YS, Peletier A, McCall Wes, Earp HS, Sartor CI. Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR and HER2 overexpressing breast cancer cell line proliferation, radiosensitization, and resistance. Int J Radiat Oncol Biol Phys 2004;58:344-352 DOI PUBMED ScienceOn |
5 | Chang GC, Tsai CM, Chen KC, et al. Predictive factors of gefitinib antitumor activity in East Asian advanced non‐small cell lung cancer patients. J Thorac Oncol. 2006;1:520-525 DOI PUBMED |
6 | Yoshida K, Yatabe Y, Park JY, et al. Prospective validation for prediction of gefitinib sensitivity by epidermal growth factor receptor gene mutation in patients with non‐small cell lung cancer. J Thorac Oncol 2007;2:22-28 DOI ScienceOn |
7 | Hegde PS, Rusnak D, Bertiaux M, et al. Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles. Mol Cancer Ther 2007;6:1629-1640 DOI ScienceOn |
8 | Konecny GE, Pegram MD, Venkatesan N, et al. Activity of the dual kinase inhibitor lapatinib (GW572016) against HER‐ 2‐overexpressing and trastuzumab‐treated breast cancer cells. Cancer Res 2006;66:1630-1639 DOI ScienceOn |
9 | Raben D, Helfrich BA, Chan D, et al. ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non‐small cell lung cancer. Semin Oncol 2002;29:37–46 |
10 | Sheridan MT, O'Dwyer T, Seymour CB, et al. Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck. Radiat Oncol Investig 1997;5:180–186 |
11 | Johnston JB, Navaratnam S, Pitz MW, et al. Targeting the EGFR pathway for cancer therapy. Curr Med Chem 2006;13:3483-3492 DOI ScienceOn |
12 | Harari PM, Huang SM. Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling. Semin Radiat Oncol 2001;11:281–289 |
13 | Balaban N, Moni J, Shannon M, et al. The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim Biophys Acta 1996;1314:147–156 |
14 | Wollman R, Yahalom J, Maxy R, et al. Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro. Int J Radiat Oncol Biol Phys 1994;30:91–98 |
15 | Bonner JA, Maihle NJ, Folven BR, et al. The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities. Int J Radiat Oncol Biol Phys 1994;29:243–247 |
16 | Kedar D, Baker CH, Killion JJ, et al. Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 2002; 8:3592–3600 |
17 | Baselga J. Targeting the epidermal growth factor receptor: a clinical reality. J Clin Oncol 2001;19:41S–44S DOI PUBMED |
18 | Dent P, Yacoub A, Contessa J, et al. Stress and radiation‐ induced activation of multiple intracellular signaling path ways. Radiat Res 2003;159:283-300 DOI ScienceOn |
19 | Harari PM, Huang SM. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Int J Radiat Oncol Biol Phys 2001; 49:427–433 |
20 | Rocha‐Lima CM, Soares HP, Raez LE, Singal R. EGFR targeting of solid tumors. Cancer Control 2007;14:295-304 DOI PUBMED |
21 | Sartor CI. Epidermal growth factor family receptors and inhibitors: radiation response modulators. Seminar in Radiation Oncology 2003;13:22‐30 |
22 | Gupta AK, McKenna WG, Weber CN, et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res 2002;8:885 –892 |
23 | Nasu S, Ang KK, Fan Z, et al. C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. Int J Radiat Oncol Biol Phys 2001;51:474–477 |
24 | Arteaga CL. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 2001;19:32S–40S |
25 | Schmidt‐Ullrich RK, Mikkelsen RB, Dent P, et al. Radiation‐induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 1997;15:1191–1197 |